Skip to main content

and
  1. Article

    Open Access

    Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation

    In 2015, the revised International Pediatric Non-Hodgkin Lymphoma Staging System was published. It mentions [18F]-FDG-PET/MRI as the latest method to perform whole-body imaging. However, supporting data are pendi...

    L. Kurch, R. Kluge, O. Sabri, L. Fischer, S. Wendt, H. Graf Einsiedel in EJNMMI Research (2021)

  2. No Access

    Article

    Elektive Stammzelltransplantation bei septischer Granulomatose

    Die septische Granulomatose („chronic granulomatous disease“, CGD) ist ein angeborener Immundefekt mit rezidivierenden Infektionen sowie erhöhtem Risiko für Autoimmunerkrankungen und Autoinflammation. Die Prog...

    C. Dedieu, J. Röhmel, U. Kölsch, J. Roesler, C. Bassir in Monatsschrift Kinderheilkunde (2016)

  3. No Access

    Article

    Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients

    Alpha-mannosidosis is a rare lysosomal storage disease. Hematopoietic SCT (HSCT) is usually recommended as a therapeutic option though reports are anecdotal to date. This retrospective multi institutional anal...

    M Mynarek, J Tolar, M H Albert, M L Escolar, J J Boelens in Bone Marrow Transplantation (2012)

  4. No Access

    Article

    Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization

     We assessed autologous bone marrow (BM) harvest and hematologic recovery after high-dose chemotherapy (HDCT) in patients who failed to achieve peripheral blood stem cell (PBSC) mobilization. One hundred and n...

    O. Rick, J. Beyer, D. Kingreen, J. S. Kühl, J. Zingsem, D. Huhn in Annals of Hematology (2000)

  5. No Access

    Article

    Spontaneous overexpression of the long form of the Bcl-X protein in a highly resistant P388 leukaemia

    A novel resistant variant of murine P388 leukaemia, P388/SPR, was identified by de novo resistance to doxorubicin (DOX) in vivo. This mutant displayed a similar level of cross-resistance to etoposide (VP-16) a...

    J-S Kühl, S Krajewski, GE Durán, JC Reed, BI Sikic in British Journal of Cancer (1997)

  6. No Access

    Article

    Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues

     The morpholinyl analogues of doxorubicin (DOX) have previously been reported to be non-cross-resistant in multidrug resistant (MDR) cells due to a lower affinity for P-glycoprotein relative to the parent comp...

    George E. Duran, Derick H. M. Lau in Cancer Chemotherapy and Pharmacology (1996)

  7. No Access

    Article

    Cytokines and pancreatic cancer

    Ten xenotransplants of human gastrointestinal carcinomas (eight human pancreatic carcinomas) were assayed for their sensitivity to human rIFN-7 and human rTNF-a in nude mice. Both substances demonstrated a dos...

    J. -S. Kühl, R. Klapdor, M. Bahlo, N. Franke in International journal of pancreatology (1989)

  8. No Access

    Article

    Cytokines and pancreatic cancer the effect of rIFN-γ, HuLelFN, rTNF-α, and LAK-cells on pancreatic and other gastrointestinal tumors in vitro

    A panel of 10 digestive tract carcinoma cell lines (6 pancreatic carcinomas) was assayed for their sensitivity to HuLelFN, human rIFN-7, rTNF-a and allogeneic human LAK-cells in vitro. In addition, a combinati...

    J-S. Kühl, R. Klapdor, H. Mohr, H. Arps in International journal of pancreatology (1989)